Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAWAKINRA study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease
2014-002715-41Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2015
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anakinra in Kawasaki disease (KD), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Achievement of body temperature below 38°C within 24 hours. Started Mar 2015; status: active.
02
Drugs
anakinra
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on 2014-002715-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002715-41.